|
1
|
Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y,
Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T, et
al: Hypoxia stimulates the EMT of gastric cancer cells through
autocrine TGFβ signaling. PLoS One. 8:e623102013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cannito S, Novo E, Compagnone A, Valfrè di
Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A,
Bozzo F, et al: Redox mechanisms switch on hypoxia-dependent
epithelial-mesenchymal transition in cancer cells. Carcinogenesis.
29:2267–2278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lester RD, Jo M, Campana WM and Gonias SL:
Erythropoietin promotes MCF-7 breast cancer cell migration by an
ERK/mitogen-activated protein kinase-dependent pathway and is
primarily responsible for the increase in migration observed in
hypoxia. J Biol Chem. 280:39273–39277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tomaskovic-Crook E, Thompson EW and Thiery
JP: Epithelial to mesenchymal transition and breast cancer. Breast
Cancer Res. 11:2132009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kotiyal S and Bhattacharya S: Breast
cancer stem cells, EMT and therapeutic targets. Biochem Biophys Res
Commun. 453:112–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo D, Wang Z and Wu J, Jiang C and Wu J:
The role of hypoxia inducible factor-1 in hepatocellular carcinoma.
Biomed Res Int. 2014:4092722014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji RC: Hypoxia and lymphangiogenesis in
tumor microenvironment and metastasis. Cancer Lett. 346:6–16. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang MH, Wu MZ, Chiou SH, Chen PM, Chang
SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by
HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai YP and Wu KJ: Hypoxia-regulated
target genes implicated in tumor metastasis. J Biomed Sci.
19:1022012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lendahl U, Lee KL, Yang H and Poellinger
L: Generating specificity and diversity in the transcriptional
response to hypoxia. Nat Rev Genet. 10:821–832. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Herreros AG, Peiró S, Nassour M and
Savagner P: Snail family regulation and epithelial mesenchymal
transitions in breast cancer progression. J Mammary Gland Biol
Neoplasia. 15:135–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Evans AJ, Russell RC, Roche O, Burry TN,
Fish JE, Chow VW, Kim WY, Saravanan A, Maynard MA, Gervais ML, et
al: VHL promotes E2 box-dependent E-cadherin transcription by
HIF-mediated regulation of SIP1and snail. Mol Cell Biol.
27:157–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bos R, van der Groep P, Greijer AE,
Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ and van
der Wall E: Levels of hypoxia-inducible factor-1α independently
predict prognosis in patients with lymph node negative breast
carcinoma. Cancer. 97:1573–1581. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei C, Xiao Q, Kuang X, Zhang T, Yang Z
and Wang L: Fucoidan inhibits proliferation of the SKM-1 acute
myeloid leukaemia cell line via the activation of apoptotic
pathways and production of reactive oxygen species. Mol Med Rep.
12:6649–6655. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boo HJ, Hong JY, Kim SC, Kang JI, Kim MK,
Kim EJ, Hyun JW, Koh YS, Yoo ES and Kwon JM: The anticancer effect
of fucoidan in PC-3 prostate cancer cells. Mar Drugs. 11:2982–2999.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen H, Cong Q, Du Z, Liao W, Zhang L, Yao
Y and Ding K: Sulfated fucoidan FP08S2 inhibits lung cancer cell
growth in vivo by disrupting angiogenesis viatargeting VEGFR2/VEGF
and blocking VEGFR2/Erk/VEGF signaling. Cancer Lett. 382:44–52.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan MD, Yao CJ, Chow JM, Chang CL, Hwang
PA, Chuang SE, Whang-Peng J and Lai GM: Fucoidan elevates
MicroRNA-29b to regulate DNMT3B MTSS1 axis and inhibit EMT in human
hepatocellular carcinoma cells. Mar Drugs. 13:6099–6116. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue M, Ge Y, Zhang J, Liu Y, Wang Q, Hou L
and Zheng Z: Fucoidan inhibited 4T1 mouse breast cancer cell growth
in vivo and in vitro via downregulation of Wnt/β-catenin signaling.
Nutr Cancer. 65:460–468. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xue M, Ge Y, Zhang J, Wang Q, Hou L, Liu
Y, Sun L and Li Q: Anticancer properties and mechanisms of fucoidan
on mouse breast cancer in vitro and in vivo. PLoS One.
7:e434832012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue M, Ji X, Xue C, Liang H, Ge Y, He X
and Zhang L, Bian K and Zhang L: Caspase-dependent and
caspase-independent induction of apoptosis in breast cancer by
fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
Biomed Pharmacother. 94:898–908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang SW, Zhang ZG, Hao YX, Zhao YL, Qian
F, Shi Y, Li PA, Liu CY and Yu PW: HIF-1α induces the
epithelial-mesenchymal transition in gastric cancer stem cells
through the Snail pathway. Oncotarget. 8:9535–9545. 2017.PubMed/NCBI
|
|
24
|
Melillo G: Targeting hypoxia cell
signaling for cancer therapy. Cancer Metastasis Rev. 26:341–352.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lesage J, Suarez-Carmona M,
Neyrinck-Leglantier D, Grelet S, Blacher S, Hunziker W, Birembaut
P, Noël A, Nawrocki-Raby B, Gilles C and Polette M: Zonula
occludens-1/NF-κB/CXCL8: A new regulatory axis for tumor
angiogenesis. FASEB J. 31:1678–1688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Semenza GL: Cancer-stromal cell
interactions mediated by hypoxia-inducible factors promote
angiogenesis, lymphangiogenesis, and metastasis. Oncogene.
32:4057–4063. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salceda S and Caro J: Hypoxia-inducible
factor 1alpha (HIF-1alpha) protein is rapidly degraded by the
ubiquitin-proteasome system under normoxic conditions. Its
stabilization by hypoxia depends on redox-induced changes. J Biol
Chem. 272:22642–22647. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Semenza GL: HIF-1: Upstream and downstream
of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shannon AM, Bouchier-Hayes DJ, Condron CM
and Toomey D: Tumor hypoxia, chemotherapeutic resistance and
hypoxia-related therapies. Cancer Treat Rev. 29:297–307. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Montagner M, Enzo E, Forcato M, Zanconato
F, Parenti A, Rampazzo E, Basso G, Leo G, Rosato A, Bicciato S, et
al: SHARP1 suppresses breast cancer metastasis by promoting
degradation of hypoxia-inducible factors. Nature. 487:380–384.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wigerup C, Påhlman S and Bexell D:
Therapeutic targeting of hypoxia and hypoxia-inducible factors in
cancer. Pharmacol Ther. 164:152–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Finger EC and Giaccia AJ: Hypoxia,
inflammation, and the tumor microenvironment in metastatic disease.
Cancer Metastasis Rev. 29:285–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chu CY, Jin YT, Zhang W, Yu J, Yang HP,
Wang HY, Zhang ZJ, Liu XP and Zou Q: CA IX is upregulated in
CoCl2-induced hypoxia and associated with cell invasive potential
and a poor prognosis of breast cancer. Int J Oncol. 48:271–280.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen D, Dang BL, Huang JZ, Chen M, Wu D,
Xu ML, Li R and Yan GR: MiR-373 drives the
epithelial-to-mesenchymal transition and metastasis via the
miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
Oncotarget. 6:32701–32712. 2015.PubMed/NCBI
|
|
38
|
Lopez D, Niu G, Huber P and Carter WB:
Tumor-induced upregulation of Twist, Snail, and Slug represses the
activity of the human VE-cadherin promoter. Arch Biochem Biophys.
482:77–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Montserrat N, Gallardo A, Escuin D,
Catasus L, Prat J, Gutiérrez-Avignó FJ, Peiró G, Barnadas A and
Lerma E: Repression of E-cadherin by SNAIL, ZEB1, and TWIST in
invasive ductal carcinomas of the breast: A cooperative effort? Hum
Pathol. 42:103–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang A, Wang Q, Han Z, Hu W, Xi L, Gao Q,
Wang S, Zhou J, Xu G, Meng L, et al: Reduced expression of Snail
decreases breast cancer cell motility by downregulating the
expression and inhibiting the activity of RhoA GTPase. Oncol Lett.
6:339–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tan EY, Yan M, Campo L, Han C, Takano E,
Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, et al: The
key hypoxia regulated gene CAIX is upregulated in basal-like breast
tumours and is associated with resistance to chemotherapy. Br J
Cancer. 100:405–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hyuga S, Wada H, Eguchi H, Otsuru T,
Iwgami Y, Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, et al:
Expression of carbonic anhydrase IX is associated with poor
prognosis through regulation of the epithelial-mesenchymal
transition in hepatocellular carcinoma. Int J Oncol. 51:1179–1190.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Svastová E, Zilka N, Zat'ovicová M,
Gibadulinová A, Ciampor F, Pastorek J and Pastoreková S: Carbonic
anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via
interaction with beta-catenin. Exp Cell Res. 290:332–345. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zuo J, Wen J, Lei M, Wen M, Li S, Lv X,
Luo Z and Wen G: Hypoxia promotes the invasion and metastasis of
laryngeal cancer cells via EMT. Med Oncol. 33:152016. View Article : Google Scholar : PubMed/NCBI
|
